All Clarivate websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Tyra Biosciences Inc. has described indazole compounds acting as fibroblast growth factor receptors (FGFR) inhibitors reported to be useful for the treatment of cancer.
